William S. Dalton BA, PhD, MD

Dr. William Dalton is CEO of M2Gen, a Moffitt Cancer Center biotechnology company. Additionally, he is founding director of Moffitt’s Personalized Medicine Institute, established in 2012 to focus on Moffitt’s brand of personalized medicine, Total Cancer Care. Dr. Dalton served as president and CEO of Moffitt from 2002 to 2012 and was instrumental in helping the Cancer Center achieve tremendous growth and innovation.
He facilitated the launch of M2Gen and the development of Moffitt Total Cancer Care. Dr. Dalton received his Ph.D. and medical degree from Indiana University School where he completed an internship in medicine. He then completed a residency in medicine and fellowships in oncology and clinical pharmacology at the University of Arizona in Tucson. He joined the University of Arizona medical school faculty, where he became professor and dean of the College of Medicine. He also directed the Bone Marrow Transplant Program at the Arizona Cancer Center.
Dr. Dalton joined Moffitt in 1996 and served as associate center director for clinical investigations and deputy director of the cancer center. He also founded and chaired the Department of Interdisciplinary Oncology at the University of South Florida where he is a professor of oncology. Dr. Dalton left Moffitt briefly in 2001 to serve as dean of the College of Medicine at the University of Arizona, returning in 2002 as the cancer center’s president, CEO and center director. A medical oncology.
Dr. Dalton has been a principal investigator or co-investigator for numerous research studies in his specialty of malignant hematology. Over his career, Dr. Dalton has published extensively, served on numerous editorial advisory boards for professional publications, participated extensively on committees for National Institute of Health/National Cancer Institute, American Association of Cancer Research, American Society of Hematology and the American Society of Clinical Oncology. He has also served on many university-based scientific advisory boards.